• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Susan Collins

Bottle and box for Aduhelm Biogen Alzheimers medicine
Pharma

Aduhelm still has big sales potential, RBC doctors' survey says

A recent doctors' survey, conducted by RBC Capital Markets, shows a strong market exists for Aduhelm, with potential for $8 billion in sales.
Kevin Dunleavy Mar 3, 2022 2:00pm
congress

If Trump teams with Dems, pricing bills might actually pass: analyst

Jan 14, 2019 10:46am
Chuck Schumer

Democrats target drug pricing again in new economic plan

Jul 24, 2017 11:17am
epipen

Mylan plans a discounted EpiPen generic. Too little, too late?

Aug 29, 2016 9:47am
epi

Mylan's 'cynical' EpiPen access plans trigger new outcry

Aug 26, 2016 8:50am
Hillary Clinton

Hillary drug-price tweet tanks biopharma stocks again

Aug 25, 2016 11:03am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings